Matthew B Robers

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Bioluminescence Technology. Top assignees: Promega Corporation, Life Technologies Corporation. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew B Robers. Retrieved from https://idiyas.com/inventor/matthew-b-robers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 150(Granted Patents)

Company Filing History:

Life Technologies Corporation

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Luciferase

Coelenterazine

Bioluminescence

Kinase Binding

Thermal Shift Assays

Oplophorus

Transmembrane Trafficking

Thienopyrrole

Functionalized Inhibitors

Structural Complementation

Broad Spectrum

Assays

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435354 - -derived luciferases, novel coelenterazine substrates, and methods of use (2025-10-07),

2. 12367513 - Activation of bioluminescence by structural complementation (2025-07-22),

3. 12366572 - Activation of bioluminescence by structural complementation (2025-07-22),

4. 12215375 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2025-02-04),

5. 12078634 - Broad spectrum kinase binding agents (2024-09-03),

6. 11899021 - Luciferase-based thermal shift assays (2024-02-13),

7. 11661623 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2023-05-30),

8. 11567083 - Luciferase-based thermal shift assays (2023-01-31),

9. 11493504 - Activation of bioluminescene by structural complementation (2022-11-08),

10. 11442063 - Broad spectrum kinase binding agents (2022-09-13),

11. 10928400 - Luciferase-based thermal shift assays (2021-02-23),

12. 10815247 - Functionalized NANOLUC inhibitors (2020-10-27),

13. 10774364 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2020-09-15),

14. 10648971 - Activation of bioluminescence by structural complementation (2020-05-12),

15. 10571471 - Luciferase-based thermal shift assays (2020-02-25),

Title: The Innovative Contributions of Matthew B Robers

Introduction

Matthew B Robers, based in Madison, WI, is a prolific inventor known for his remarkable contributions to biochemistry and molecular biology. With a total of 25 patents to his name, Robers has made significant advancements in the field of luciferases and protein kinase detection technologies, influencing research and applications widely.

Latest Patents

Robers's latest patents showcase his innovation in the area of luciferase technology. One notable patent involves Oplophorus-derived luciferases, which includes isolated polynucleotides encoding modified luciferase polypeptides. These include substrates that enhance luminescence, signal stability, and protein stability compared to wild-type variants. Another significant patent presents broad-spectrum kinase binding agents, providing detectable tracers for the identification of protein kinases, thereby facilitating advances in biomolecular research and drug development.

Career Highlights

Throughout his career, Robers has worked with reputed companies, enhancing the field of biotechnology. Notably, he was associated with Promega Corporation and Life Technologies Corporation, where his innovative ideas and research have driven forward multiple projects and applications in life sciences. His background in these prominent companies has contributed to his extensive knowledge and expertise in developing cutting-edge technology.

Collaborations

In his journey as an inventor, Robers has collaborated with notable colleagues including Brock Binkowski and Lance P Encell. These partnerships have led to fruitful exchanges of ideas, ultimately resulting in significant scientific advancements and multiple successful patent applications.

Conclusion

Matthew B Robers' innovative spirit and contributions have undeniably shaped the landscape of biotechnology and molecular biology. His extensive portfolio of patents and collaborations with leading professionals in the field highlight his commitment to research and innovation, paving the way for future discoveries in scientific arenas.

Profile summary based on public USPTO records.